A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting where good ideas are being implemented, it encourages their wider uptake.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Overall ranking Vacancies Funding Methodology Key Finding
Researcher

Adrián Alonso Ruiz

Adrián Alonso Ruiz is a Researcher, part of the research team for the Antimicrobial Resistance Benchmark assessing companies’ approach to antimicrobial stewardship. He holds a BSc. in Pharmacy from Madrid’s Complutense University and a MSc. in Global Health from Barcelona’s Institute for Global Health (ISGlobal-University of Barcelona) and Heidelberg University as part of the tropEd network for higher education in International Health. During his master’s degree he focused on Health Systems Strengthening and access to medicines, presenting his thesis about the relation between international trade law and Pharmaceutical Systems.

Prior joining the Foundation, Adrián worked as a community pharmacist in Madrid and as a clinical laboratory technician in Patzún, Guatemala; where he also assessed a programme to control and reduce the incidence of Diabetes in the community.

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.